3 YEAR FOLLOW-UP OF PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE

被引:165
作者
SCHINDLBECK, NE
KLAUSER, AG
BERGHAMMER, G
LONDONG, W
MULLERLISSNER, SA
机构
[1] Department of Gastroenterology, Medizinische Klinik, University of Munich
关键词
D O I
10.1136/gut.33.8.1016
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Data on the natural course of gastrooesophageal reflux disease are sparse. One hundred and sixty six patients with typical reflux symptoms (heartburn and/or acid regurgitation) and pathologic pH monitoring (reflux time >8.2% upright and/or >3.0% supine) were studied. The patients were followed up by questionnaire and interview for a mean of 41 (seven to 86) months after diagnosis of reflux disease. Ten patients had died of diseases not reflux related. In 117 (75%) of the remaining 156 patients data on the course of gastrooesophageal reflux disease could be obtained. In 12 patients anti reflux surgery had been performed. Forty one (39%) of the remaining 105 patients have stopped taking medical therapy, in 13 of these patients symptoms had completely disappeared. Sixty four patients continued on medication (40 on demand, 24 regularly). When asked how their symptoms would be if they completely stopped medication, 71 patients considered their symptoms to be equal or worse and 21 patients to be improved as compared with the initial investigation. Patients with persisting symptoms at follow up had significantly more supine-reflux (p<0.05) at the initial pH monitoring as compared with patients with improved symptoms. The presence and grade of oesophageal erosions at initial endoscopy, duration of symptoms, age, sex, and smoking habits had no influence on the course of gastrooesophageal reflux disease. In conclusion, reflux symptoms disappear only in a minority of patients with proven gastrooesophageal reflux disease. More than half of all patients continue medication, either on demand or regularly. Severe supine reflux is an unfavourable prognostic factor.
引用
收藏
页码:1016 / 1019
页数:4
相关论文
共 18 条
  • [1] MEDICAL AND SURGICAL MANAGEMENT OF REFLUX ESOPHAGITIS - 38-MONTH REPORT ON A PROSPECTIVE CLINICAL TRIAL
    BEHAR, J
    SHEAHAN, DG
    BIANCANI, P
    SPIRO, HM
    STORER, EH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (06) : 263 - 268
  • [2] DAYTIME GASTROESOPHAGEAL REFLUX IS IMPORTANT IN ESOPHAGITIS
    DECAESTECKER, JS
    BLACKWELL, JN
    PRYDE, A
    HEADING, RC
    [J]. GUT, 1987, 28 (05) : 519 - 526
  • [3] DEMEESTER TR, 1980, J THORAC CARDIOV SUR, V79, P656
  • [4] HEADING RC, 1989, SCAND J GASTROENTERO, V24, P33
  • [5] HEALING AND RELAPSE OF SEVERE PEPTIC ESOPHAGITIS AFTER TREATMENT WITH OMEPRAZOLE
    HETZEL, DJ
    DENT, J
    REED, WD
    NARIELVALA, FM
    MACKINNON, M
    MCCARTHY, JH
    MITCHELL, B
    BEVERIDGE, BR
    LAURENCE, BH
    GIBSON, GG
    GRANT, AK
    SHEARMAN, DJC
    WHITEHEAD, R
    BUCKLE, PJ
    [J]. GASTROENTEROLOGY, 1988, 95 (04) : 903 - 912
  • [6] GASTROESOPHAGEAL REFLUX DISEASE - ACUTE AND MAINTENANCE TREATMENTS WITH CIMETIDINE
    KAUL, B
    PETERSEN, H
    ERICHSEN, H
    MYRVOLD, HE
    GRETTE, K
    HALVORSEN, T
    FJOSNE, U
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1986, 21 (02) : 139 - 145
  • [7] KLAUSER AG, 1990, AM J GASTROENTEROL, V85, P1463
  • [8] KOELZ HR, 1989, SCAND J GASTROENTERO, V24, P25
  • [9] HEALING AND RELAPSE OF REFLUX ESOPHAGITIS DURING TREATMENT WITH RANITIDINE
    KOELZ, HR
    BIRCHLER, R
    BRETHOLZ, A
    BRON, B
    CAPITAINE, Y
    DELMORE, G
    FEHR, HF
    FUMAGALLI, I
    GEHRIG, J
    GONVERS, JJ
    HALTER, F
    HAMMER, B
    KAYASSEH, L
    KOBLER, E
    MILLER, G
    MUNST, G
    PELLONI, S
    REALINI, S
    SCHMID, P
    VOIROL, M
    BLUM, AL
    [J]. GASTROENTEROLOGY, 1986, 91 (05) : 1198 - 1205
  • [10] MEDICAL THERAPY FOR CHRONIC REFLUX ESOPHAGITIS
    LIEBERMAN, DA
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (10) : 1717 - 1720